1. Home
  2. MDXH

as of 12-30-2025 3:28pm EST

$3.53
+$0.18
+5.37%
Stocks Nasdaq

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Founded: 2003 Country:
Belgium
Belgium
Employees: N/A City: N/A
Market Cap: 167.8M IPO Year: 2021
Target Price: $7.67 AVG Volume (30 days): 114.5K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.64 EPS Growth: N/A
52 Week Low/High: $1.35 - $5.33 Next Earning Date: 11-12-2025
Revenue: $103,069,000 Revenue Growth: 21.68%
Revenue Growth (this year): 23.34% Revenue Growth (next year): 22.98%

AI-Powered MDXH Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.51%
75.51%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest MDxHealth SA News

MDXH Breaking Stock News: Dive into MDXH Ticker-Specific Updates for Smart Investing

All MDXH News

Share on Social Networks: